High circulating HER2 extracellular domain levels correlate with reduced efficacy of an aromatase inhibitor in hormone receptor-positive metastatic breast cancer: A confirmatory prospective study
2010 ◽
Vol 125
(1)
◽
pp. 137-143
◽
2011 ◽
2018 ◽
2015 ◽
Vol 154
(2)
◽
pp. 287-297
◽